Nuvectis Pharma Return on Net Operating Assets Trends

Nuvectis Pharma, Inc. (NVCT)

23.87 +0.31 (+1.32%) USD | NASDAQ | Aug 24, 16:00

23.86 -0.01 (-0.04%) After-Hours: 20:00

View Return on Net Operating Assets for NVCT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View and export this data back to . Start Trial.

Date	Value

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

Decoy Therapeutics, Inc.	Upgrade
Unicycive Therapeutics, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Anika Therapeutics, Inc.	Upgrade